Schlieren/London - Daniela Marino has been named on the list of 30 Rising Leaders in the healthcare industry for 2023. The list is produced by the online journal In Vivo. Marino is the CEO of the biotechnology firm Cutiss AG.

Daniela Marino, CEO at Cutiss, named as Rising Leader
Daniela Marino, CEO a Cutiss. Images PwC and Cutiss.

Daniela Marino is among the 30 most important people in the global healthcare sector. The CEO of Cutiss AG, a biotechnology company based in Schlieren in the canton of Zurich, has been included in the list of Rising Leaders for 2023 produced by the British journal In Vivo, further details of which can be found in a press release. The fourth annual list of Rising Leaders is made up of entrepreneurs and innovators from across the world. The 2023 list also includes investors, CEOs of small and medium-sized enterprises (SMEs), employees at major biopharmaceutical and medtech firms as well as other people who have developed unique healthcare initiatives.

There is a short profile of each of the 30 Rising Leaders on In Vivo. Daniela Marino is the CEO and co-founder of Cutiss with a Master's degree in biotechnology and a PhD in sciences from the Swiss Federal Institute of Technology in Zurich (ETH). Marino’s research has focused on vascular biology and skin engineering.

Once I’ve set my mind to something, I see it through to the end.
Daniela Marino, CEO Cutiss
Daniela Marino - CEO Cutiss in an interview with PwC Switzerland

Founded in 2017, Cutiss focuses on areas such as regenerative medicine, tissue engineering, and skin pigmentation. The company’s lead product is denovoSkin. To create the personalized human skin graft, a small, post-stamp-sized piece of healthy skin is used as the basis for bioengineering large pieces of skin that can then be transplanted. The skin graft grows with the patient, which is particularly important in children. Moreover, Cutiss has developed the world’s first machine with the ability to automate the entire production process of the personalized skin graft.

Cutiss was founded as a spin-off from the University of Zurich and is headquartered at the Bio-Technopark Schlieren-Zurich. ce/gba 

CUTISS denovoCast. Video: Cutiss

Life Science Hub Greater Zurich Area

Life Science Hub Greater Zurich Area

The Greater Zurich Area has evolved into a dynamically expanding life sciences hotspot, thanks to the region’s academic excellence, business-friendly regulations, IP protection, large international talent pool and R&D collaborations between universities and start-ups, as well as large multinational corporations.

BioTech Greater Zurich Area

Contact us

Can we put you in touch with a peer company or research institute? Do you need any information regarding your strategic expansion to Switzerland's technology and business center?